Poland· PL-100117408
Maść ichtiolowa
A medicinal product containing ammonii bituminosulfonatis unguentum, registered in Poland by Laboratorium Farmaceutyczne AVENA Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Ammonii bituminosulfonatis unguentum
- Manufacturer
- Laboratorium Farmaceutyczne AVENA Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909994331815
- gtin05909994331822
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f35b5396-e574-4605-953f-533620df0570 GET /v1/drugs/f35b5396-e574-4605-953f-533620df0570?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "10%",
"packaging": "05909994331815 ¦ OTC ¦ 21758\n1 op. 20 g\n05909994331822 ¦ OTC ¦ 21759\n1 op. 500 g",
"substance": "Ammonii bituminosulfonas ad 1 ml",
"common_name": "Ammonii bituminosulfonatis unguentum",
"pl_product_id": "100117408",
"pozwolenie_nr": "IL-3318/ChF",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about ammonii bituminosulfonatis unguentum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.